Skip to main content
Caplight Logo









OncoTag

OncoTag

Private
Nova LimaHealthcare & Life Scienceshttps://oncotag.com.br/

Last Round

Grant

Oct 19, 2023

Total Funding Raised

$75,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OncoTag is a biotechnology company that operates a genetic analysis laboratory focused on precision oncology by developing molecular tests to assist in the treatment of cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticsprecision medicineNGSnext-generation sequencingoncology diagnosticsgenetic testingcancer genomicspersonalized cancer treatmentai-driven diagnosticsbioinformaticsqRT-PCRclinical decision supportmedtechhealthtechai in healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoTag Comparables

Compare OncoTag with similar companies based on industry and business-model similarity.

OncoTag comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Onkos Diagnósticos Moleculares
79%
OncoDNA
77%
Mendelics Análise Genômica
76%

OncoTag Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 19, 2023
SeedAug 8, 2023
AcceleratorOct 15, 2018

Key People

Founding team and executive leadership

Leticia Braga

Chief Executive Officer

Executive Team

MSc Pedro Villar

Pesquisador Imunologista Pesquisa Translacional Em Oncologia CEO, CEO - Chief Executive Officer, CEO

Executive Team

OncoTag Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 36% MoM.

  • May 3, 2026

    Grew 50% QoQ from 6 to 9 employees.

OncoTag Filings

Explore SEC and related filing metadata, where available.

OncoTag filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OncoTag's valuation, stock price, and market status.

Is OncoTag a public or private company?

OncoTag is a private company.

What is the current stock price of OncoTag?

OncoTag is a private company with no public stock price. No recent secondary market data is available.

How much is OncoTag worth (valuation)?

Valuation information for OncoTag is not publicly available.

Can I buy OncoTag stock?

OncoTag shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OncoTag's last funding round?

OncoTag's most recent funding round was Grant on October 19, 2023.

Who are the main investors in OncoTag?

Key investors in OncoTag include BiotechTown.

Will OncoTag IPO soon?

No public IPO plans have been announced for OncoTag.

How can I track OncoTag secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoTag's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNova Lima
Employee Range8
Year Founded2014
Last FundingOct 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?